These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 17156479)

  • 21. Systematic review and meta-analysis of combination therapy for smoking cessation.
    Shah SD; Wilken LA; Winkler SR; Lin SJ
    J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
    Sicras Mainar A; Navarro Artieda R; Díaz Cerezo S; Martí Sánchez B; Sanz De Burgoa V
    Aten Primaria; 2011 Sep; 43(9):482-9. PubMed ID: 21382649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking cessation-recent advances.
    McNeil JJ; Piccenna L; Ioannides-Demos LL
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
    Eisenberg MJ; Filion KB; Yavin D; Bélisle P; Mottillo S; Joseph L; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Pilote L
    CMAJ; 2008 Jul; 179(2):135-44. PubMed ID: 18625984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
    Wu L; Sun S; He Y; Zeng J
    Int J Environ Res Public Health; 2015 Aug; 12(9):10235-53. PubMed ID: 26308034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which drug to be used in smoking cessation?
    Tønnesen P
    Pol Arch Med Wewn; 2008 Jun; 118(6):373-6. PubMed ID: 18619194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
    Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS
    Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
    Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T
    Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
    Mills EJ; Thorlund K; Eapen S; Wu P; Prochaska JJ
    Circulation; 2014 Jan; 129(1):28-41. PubMed ID: 24323793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventions for preventing weight gain after smoking cessation.
    Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
    Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
    Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    Rose JE; Behm FM
    Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.
    Leeman RF; Huffman CJ; O'Malley SS
    Alcohol Alcohol; 2007; 42(3):196-206. PubMed ID: 17526629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials.
    Guo K; Wang S; Shang X; E F; Hou L; Li J; Li Y; Yang K; Li X
    Addict Behav; 2022 Aug; 131():107329. PubMed ID: 35397262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.